227 related articles for article (PubMed ID: 30448921)
1. Probing the mechanism of SIRT1 activation by a 1,4-dihydropyridine.
Manna D; Bhuyan R; Ghosh R
J Mol Model; 2018 Nov; 24(12):340. PubMed ID: 30448921
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol serves as a protein-substrate interaction stabilizer in human SIRT1 activation.
Hou X; Rooklin D; Fang H; Zhang Y
Sci Rep; 2016 Nov; 6():38186. PubMed ID: 27901083
[TBL] [Abstract][Full Text] [Related]
3. Assessing the performance of three resveratrol in binding with SIRT1 by molecular dynamics simulation and MM/GBSA methods: the weakest binding of resveratrol 3 to SIRT1 triggers a possibility of dissociation from its binding site.
Chen H; Wang Y; Gao Z; Yang W; Gao J
J Comput Aided Mol Des; 2019 Apr; 33(4):437-446. PubMed ID: 30805760
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resveratrol.
Cao D; Wang M; Qiu X; Liu D; Jiang H; Yang N; Xu RM
Genes Dev; 2015 Jun; 29(12):1316-25. PubMed ID: 26109052
[TBL] [Abstract][Full Text] [Related]
5. Multiscale landscape of molecular mechanism of SIRT1 activation by STACs.
Liu F; Yang N
Phys Chem Chem Phys; 2020 Jan; 22(2):826-837. PubMed ID: 31840716
[TBL] [Abstract][Full Text] [Related]
6. Quercetin 3,5,7,3',4'-pentamethyl ether from Kaempferia parviflora directly and effectively activates human SIRT1.
Zhang M; Lu P; Terada T; Sui M; Furuta H; Iida K; Katayama Y; Lu Y; Okamoto K; Suzuki M; Asakura T; Shimizu K; Hakuno F; Takahashi SI; Shimada N; Yang J; Ishikawa T; Tatsuzaki J; Nagata K
Commun Biol; 2021 Feb; 4(1):209. PubMed ID: 33608631
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics simulation and molecular docking studies of 1,4-Dihydropyridines as P-glycoprotein's allosteric inhibitors.
Shahraki O; Zargari F; Edraki N; Khoshneviszadeh M; Firuzi O; Miri R
J Biomol Struct Dyn; 2018 Jan; 36(1):112-125. PubMed ID: 27981890
[TBL] [Abstract][Full Text] [Related]
8. Ligand and structure-based approaches for the identification of SIRT1 activators.
Vyas VK; Goel A; Ghate M; Patel P
Chem Biol Interact; 2015 Feb; 228():9-17. PubMed ID: 25595223
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Assay of SIRT1-Activating Compounds.
Dai H; Ellis JL; Sinclair DA; Hubbard BP
Methods Enzymol; 2016; 574():213-244. PubMed ID: 27423864
[TBL] [Abstract][Full Text] [Related]
10. The 2.5 Å crystal structure of the SIRT1 catalytic domain bound to nicotinamide adenine dinucleotide (NAD+) and an indole (EX527 analogue) reveals a novel mechanism of histone deacetylase inhibition.
Zhao X; Allison D; Condon B; Zhang F; Gheyi T; Zhang A; Ashok S; Russell M; MacEwan I; Qian Y; Jamison JA; Luz JG
J Med Chem; 2013 Feb; 56(3):963-9. PubMed ID: 23311358
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis of allosteric peptide activator for human SIRT1 and its biological evaluation in cellular model of Alzheimer's disease.
Kumar R; Nigam L; Singh AP; Singh K; Subbarao N; Dey S
Eur J Med Chem; 2017 Feb; 127():909-916. PubMed ID: 27836195
[TBL] [Abstract][Full Text] [Related]
12. 1,4-Dihydropyridine (DHP) suppresses against oxidative stress in nucleus pulposus via activating sirtuin-1.
Song Y; Wang Z; Liu L; Zhang S; Zhang H; Qian Y
Biomed Pharmacother; 2020 Jan; 121():109592. PubMed ID: 31706101
[TBL] [Abstract][Full Text] [Related]
13. Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain.
Huber I; Wappl E; Herzog A; Mitterdorfer J; Glossmann H; Langer T; Striessnig J
Biochem J; 2000 May; 347 Pt 3(Pt 3):829-36. PubMed ID: 10769189
[TBL] [Abstract][Full Text] [Related]
14. Novel 1,4-dihydropyridine induces apoptosis in human cancer cells through overexpression of Sirtuin1.
Manna D; Bhuyan R; Saikh F; Ghosh S; Basak J; Ghosh R
Apoptosis; 2018 Oct; 23(9-10):532-553. PubMed ID: 30203236
[TBL] [Abstract][Full Text] [Related]
15. Mounting evidence validates Ursolic Acid directly activates SIRT1: A powerful STAC which mimic endogenous activator of SIRT1.
Bakhtiari N; Mirzaie S; Hemmati R; Moslemee-Jalalvand E; Noori AR; Kazemi J
Arch Biochem Biophys; 2018 Jul; 650():39-48. PubMed ID: 29758202
[TBL] [Abstract][Full Text] [Related]
16. Molecular and Cellular Characterization of SIRT1 Allosteric Activators.
Schultz MB; Rinaldi C; Lu Y; Amorim JA; Sinclair DA
Methods Mol Biol; 2019; 1983():133-149. PubMed ID: 31087296
[TBL] [Abstract][Full Text] [Related]
17. Structural analysis of the inhibitory effects of polyphenols, (+)-hopeaphenol and (-)-isohopeaphenol, on human SIRT1.
Loisruangsin A; Hikita K; Seto N; Niwa M; Takaya Y; Kaneda N
Biofactors; 2019 Mar; 45(2):253-258. PubMed ID: 30537158
[TBL] [Abstract][Full Text] [Related]
18. SIRT1 activation by small molecules: kinetic and biophysical evidence for direct interaction of enzyme and activator.
Dai H; Kustigian L; Carney D; Case A; Considine T; Hubbard BP; Perni RB; Riera TV; Szczepankiewicz B; Vlasuk GP; Stein RL
J Biol Chem; 2010 Oct; 285(43):32695-32703. PubMed ID: 20702418
[TBL] [Abstract][Full Text] [Related]
19. Two novel SIRT1 activators, SCIC2 and SCIC2.1, enhance SIRT1-mediated effects in stress response and senescence.
Scisciola L; Sarno F; Carafa V; Cosconati S; Di Maro S; Ciuffreda L; De Angelis A; Stiuso P; Feoli A; Sbardella G; Altucci L; Nebbioso A
Epigenetics; 2020; 15(6-7):664-683. PubMed ID: 31942817
[TBL] [Abstract][Full Text] [Related]
20. Binding mechanisms of 1,4-dihydropyridine derivatives to L-type calcium channel Cav1.2: a molecular modeling study.
Xu L; Li D; Tao L; Yang Y; Li Y; Hou T
Mol Biosyst; 2016 Feb; 12(2):379-90. PubMed ID: 26673131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
